Results 51 to 60 of about 9,904,701 (157)
EFFECTS OF CHEMOTHERAPY ON RED BLOOD CELL ALLOIMMUNIZATION IN CHILDREN [PDF]
Background: Red cell transfusions can lead to alloimmunization; however, pediatric alloimmunization frequency has not been well studied, and it may vary among diagnostic subgroups. Subgroups such as pediatric hematology/oncology patients require numerous
SOLH, ZIAD
core +1 more source
Amr J Halawani,1 Abdullah A Mobarki,2 Ali H Arjan,3 Muhammad Saboor,2 Hassan A Hamali,2 Gasim Dobie,2 Khalaf F Alsharif4 1Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia; 2Department of
Halawani AJ +6 more
doaj
Transfusion support remains the mainstay of supportive treatment for thalassemia patients in spite of recent advances such as stem cell transplantation and gene therapy.
Debasish Mishra +3 more
doaj +1 more source
The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations
ABSTRACT Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy.
Mar Bennasar, Antoni Borrell
wiley +1 more source
Yona Mbalibulha,1 Bernard Natukunda,1 Andrew Livex Okwi,2 Joan N Kalyango,3 Kajja Isaac,4 Sam Ononge5 1Department of Medical Laboratory Science, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; 2Department of Pathology,
Mbalibulha Y +5 more
doaj
Abstract Background Thrombocytopenia arises from heterogeneous inherited and acquired disorders, and identifying the underlying platelet clearance mechanisms remains challenging. Platelet desialylation, characterised by loss of sialic acid and consequent exposure of terminal β‐galactose residues recognised by the Ashwell–Morell receptor, represents an ...
Karen Nogueira Chinoca Ziza +14 more
wiley +1 more source
Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike +33 more
wiley +1 more source
Extensive red blood cell matching considering patient alloimmunization risk [PDF]
Background and Objectives: Red blood cell (RBC) transfusions pose a risk of alloantibody development in patients. For patients with increased alloimmunization risk, extended preventive matching is advised, encompassing not only the ABO-D blood groups but
van der Schoot, C. Ellen +9 more
core +3 more sources
Red cell alloimmunization among haemato-oncologic patients in a teaching hospital in Malaysia
Background: The aim of the study is to estimate the prevalence and specificity of red blood cell alloantibody among haemato-oncologic patients and to correlate the association of antibody development with other factors such as age, gender, race, number ...
Noor Haslina Mohd Noor +3 more
doaj +1 more source
Frequency and Types of Red Cell Alloantibodies in Pregnant Females
Introduction: Maternal isoimmunization, also called alloimmunization, occurs when immune system of a pregnant female is sensitized to foreign RBC surface antigen producing immune process.
Asma Munir +4 more
doaj +1 more source

